Under assault from newer therapies in the anti-inflammatory market, Johnson & Johnson has focused on expanding Stelara beyond dermatology—and Monday, it took another big step in that direction. The ...
Remicade comes as a powder. A healthcare professional mixes the powder with liquid to form a solution, which they give as an intravenous (IV) infusion. (This is an injection into a vein given over ...
Johnson & Johnson's big-selling Remicade has held most of its ground against biosimilar competition, thanks in part to some aggressive payer contracts that rivals—including Pfizer—have called into ...
SAN ANTONIO, TX, February 1, 2008 -- Data from an integrated analysis of three randomized, placebo-controlled trials showed patients with moderate to severe plaque psoriasis receiving REMICADE ...
Johnson & Johnson’s Remicade, which remains one of the world’s best-selling drugs, is one step closer to facing competition after a FDA advisory committee voted 21-3 in support of approving a ...
PHILADELPHIA, PA, October 15, 2007- Clinical data presented today at the annual meeting of the American College of Gastroenterology (ACG) show that REMICADE significantly reduces the incidence of ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Patients with Crohn’s disease who were biologic naive ...
Inflammatory bowel disease (IBD) is a serious digestive disease of the small intestine and colon; and includes Crohn’s disease and ulcerative colitis. Now, doctors are testing a new use for an ...
In this clip from The Motley Fool's Industry Focus: Healthcare podcast, Kristine Harjes is joined by Todd Campbell to discuss Remicade's first-quarter sales and how the company's responding to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results